| 词条 | Estradiol dipropionate/hydroxyprogesterone caproate |
| 释义 |
| image = Estradiol dipropionate.svg | width = 250px | caption = | image2 = Hydroxyprogesterone caproate.svg | width2 = 250px | caption2 = Estradiol dipropionate (top) and hydroxyprogesterone caproate (bottom) | type = combo | drug_name = Estradiol dipropionate / hydroxyprogesterone caproate | component1 = Estradiol dipropionate | class1 = Estrogen | component2 = Hydroxyprogesterone caproate | class2 = Progestogen | tradename = EP Hormone Depot | Drugs.com = | MedlinePlus = | licence_EU = | licence_US = | DailyMedID = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = Intramuscular injection | CAS_number = | CAS_supplemental = | ATCvet = | ATC_prefix = G03 | ATC_suffix = FA02 | ATC_supplemental = | PubChem = | PubChemSubstance = 17398112 | IUPHAR_ligand = | DrugBank = | ChemSpiderID = | UNII = | KEGG = D04457 | ChEBI = | ChEMBL = | synonyms = EDP/OHPC }}Estradiol dipropionate/hydroxyprogesterone caproate (EDP/OHPC), sold under the brand name EP Hormone Depot, is a combined estrogen–progestogen medication which is used in Japan.[1][2][3][4][5][6][7][8] It is manufactured by Teikoku Zoki Pharmaceutical Co., Tokyo and contains 1 mg/mL estradiol dipropionate and 50 mg/mL hydroxyprogesterone caproate.[2][3][4][5][6][7][8] See also
References1. ^https://www.drugs.com/international/ep-hormone.html {{Birth control methods}}{{Hormonal contraceptives}}{{Estrogen receptor modulators}}{{Progesterone receptor modulators}}{{DEFAULTSORT:Estradiol dipropionate hydroxyprogesterone caproate}}{{Portal bar|Pharmacy and pharmacology|Medicine}}2. ^1 {{cite journal | vauthors = Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M | title = The estrogenic and antiestrogenic activities of droloxifene in human breast cancers | journal = Jpn. J. Pharmacol. | volume = 63 | issue = 1 | pages = 27–34 | date = September 1993 | pmid = 8271528 | doi = 10.1254/jjp.63.27 | url = }} 3. ^1 {{cite journal | vauthors = Asanuma F, Yamada Y, Kawamura E, Lee K, Kobayashi H, Yamada T, Suzuki T, Kubota T | title = Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27 | journal = Folia Microbiol. (Praha) | volume = 43 | issue = 5 | pages = 473–4 | date = 1998 | pmid = 9821299 | doi = 10.1007/BF02820793 | url = }} 4. ^1 {{cite journal | vauthors = Noguchi M, Tajiri K, Taniya T, Kumaki T, Ashikari A, Miyazaki I | title = Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7) | journal = Oncology | volume = 47 | issue = 1 | pages = 19–24 | date = 1990 | pmid = 2137212 | doi = 10.1159/000226779 | url = }} 5. ^1 {{cite journal | vauthors = Kubota T, Oka S, Utsumi T, Inoue S, Kuzuoka M, Suto A, Arisawa Y, Ishibiki K, Abe O | title = Human breast carcinoma (ZR-75-1) serially transplanted into nude mice--with reference to estradiol dependency and sensitivity to tamoxifen | journal = Jpn J Surg | volume = 19 | issue = 4 | pages = 446–51 | date = July 1989 | pmid = 2810959 | doi = 10.1007/BF02471626 | url = }} 6. ^1 {{cite journal | vauthors = Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M | title = FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity | journal = J. Antibiot. | volume = 47 | issue = 3 | pages = 301–10 | date = March 1994 | pmid = 7513682 | doi = 10.7164/antibiotics.47.301 | url = }} 7. ^1 {{cite journal | vauthors = Hori Y, Abe Y, Nishimura M, Goto T, Okuhara M, Kohsaka M | title = R1128 substances, novel non-steroidal estrogen-receptor antagonists produced by a Streptomyces. III. Pharmacological properties and antitumor activities | journal = J. Antibiot. | volume = 46 | issue = 7 | pages = 1069–75 | date = July 1993 | pmid = 8360101 | doi = 10.7164/antibiotics.46.1055 | url = }} 8. ^1 {{cite journal | vauthors = Noguchi M, Koyasaki N, Miyazaki I, Mizukami Y | title = Effects of hormones on tumor growth and immunoreactive insulin-like growth factor-1 of estrogen receptor-positive human breast cancer (MCF-7) transplanted in nude mice | journal = Jpn. J. Cancer Res. | volume = 82 | issue = 11 | pages = 1199–202 | date = November 1991 | pmid = 1752778 | pmc = 5918318 | doi = 10.1111/j.1349-7006.1991.tb01780.x | url = }} 1 : Combined estrogen–progestogen formulations |
| 随便看 |
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。